← Back to Screener
AETHLON MEDICAL INC (AEMD)
Price$2.41
Growth ScoreA
Momentum ScoreD
Favorite Metrics
Price vs S&P 500 (26W)-54.03%
Price vs S&P 500 (4W)-8.88%
VGM Score67.06
Market Capitalization$3.47M
All Metrics
Book Value / Share (Quarterly)$6.90
P/TBV (Annual)1.12x
Indicated Dividend (Annual)$0.00
Cash Flow / Share (Quarterly)$-7.11
Price vs S&P 500 (YTD)-31.15%
Net Profit Margin (TTM)-433.33%
EPS (TTM)$-49.09
10-Day Avg Trading Volume3.04M
EPS Excl Extra (TTM)$-49.09
EPS (Annual)$-8.33
ROI (Annual)-253.73%
Net Profit Margin (5Y Avg)-2114.43%
Cash / Share (Quarterly)$7.15
ROA (Last FY)-176.64%
Revenue Growth TTM (YoY)96.55%
EBITD / Share (TTM)$-17.49
ROE (5Y Avg)-137.98%
Operating Margin (TTM)-435.09%
Cash Flow / Share (Annual)$-29.57
P/B Ratio0.52x
P/B Ratio (Quarterly)0.31x
Net Income / Employee (Annual)$-1,444,400
EV / Revenue (TTM)-6.12x
Net Interest Coverage (TTM)-126.60x
ROA (TTM)-164.33%
EPS Incl Extra (Annual)$-8.33
Current Ratio (Annual)3.13x
Quick Ratio (Quarterly)5.53x
3-Month Avg Trading Volume0.38M
52-Week Price Return-92.61%
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$6.90
P/S Ratio (Annual)6.08x
Asset Turnover (Annual)0.03x
52-Week High$31.60
Operating Margin (5Y Avg)-2098.21%
EPS Excl Extra (Annual)$-8.33
Tangible BV CAGR (5Y)-11.34%
26-Week Price Return-38.10%
Quick Ratio (Annual)2.90x
13-Week Price Return10.50%
Total Debt / Equity (Annual)0.00x
Current Ratio (Quarterly)5.68x
Enterprise Value$-3.49M
Asset Turnover (TTM)0.03x
Book Value / Share Growth (5Y)14.64%
Revenue / Employee (Annual)$0
Pretax Margin (Annual)-2110.53%
Cash / Share (Annual)$21.28
3-Month Return Std Dev93.95%
Net Income / Employee (TTM)$-1,280,200
ROE (Last FY)-253.73%
Net Interest Coverage (Annual)-30.04x
EPS Basic Excl Extra (Annual)$-8.33
Receivables Turnover (TTM)8.77x
Total Debt / Equity (Quarterly)0.00x
EPS Incl Extra (TTM)$-49.09
Receivables Turnover (Annual)8.77x
ROI (TTM)-219.40%
P/S Ratio (TTM)6.08x
Pretax Margin (5Y Avg)-2116.99%
Revenue / Share (Annual)$0.00
Tangible BV / Share (Annual)$19.82
Price vs S&P 500 (52W)-120.81%
Year-to-Date Return-20.22%
5-Day Price Return0.45%
EPS Normalized (Annual)$-8.33
ROA (5Y Avg)-104.21%
Net Profit Margin (Annual)-2112.28%
Month-to-Date Return-0.90%
Cash Flow / Share (TTM)$-4.75
EBITD / Share (Annual)$-5.77
Operating Margin (Annual)-2112.28%
LT Debt / Equity (Annual)0.00x
ROI (5Y Avg)-137.98%
LT Debt / Equity (Quarterly)0.00x
EPS Basic Excl Extra (TTM)$-49.09
P/TBV (Quarterly)0.31x
P/B Ratio (Annual)1.12x
Pretax Margin (TTM)-433.33%
Book Value / Share (Annual)$19.82
Price vs S&P 500 (13W)0.75%
Beta1.32x
Revenue / Share (TTM)$0.00
ROE (TTM)-219.40%
52-Week Low$1.36
gGradeA
mGradeD
vgmGradeB
Show chart for
Analyst Recommendations
Feb 2026
Mar 2026
Apr 2026
May 2026
2.29
2.29
2.29
2.29
Industry Peers — Surgical & Medical Instruments(138)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
AEMDAETHLON MEDICAL INC | — | A | D | $2.41 |
| SYKStryker Corporation | C | C | D | $299.46 |
| MMM3M Company | C | F | C | $150.93 |
| BSXBoston Scientific Corp. | C | B | F | $47.98 |
| MDLNMedline Inc. Class A common stock | C | D | D | $35.75 |
| BDXBecton, Dickinson and Co. | B | C | C | $145.33 |
| DXCMDexCom, Inc. | C | B | C | $74.87 |
| RMDResMed Inc. | B | B | D | $186.44 |
| WSTWest Pharmaceutical Services, Inc. | D | C | B | $316.30 |
| SOLVSolventum Corporation | C | D | C | $75.84 |
| PENPenumbra, Inc. | F | C | C | $318.95 |
About
Aethlon Medical is a medical device company developing the Hemopurifier, a clinical-stage therapeutic device designed to remove cancer cells and life-threatening viruses from the circulatory system. The platform addresses significant unmet needs in cancer treatment and biodefense through novel blood purification technology.